Lahiru Handunnetthi
Lahiru Handunnetthi
Academic Neurologist, University of Oxford
Verified email at - Homepage
Cited by
Cited by
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution
SV Ramagopalan, A Heger, AJ Berlanga, NJ Maugeri, MR Lincoln, ...
Genome research 20 (10), 1352-1360, 2010
Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D
SV Ramagopalan, NJ Maugeri, L Handunnetthi, MR Lincoln, SM Orton, ...
PLoS genetics 5 (2), e1000369, 2009
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
M Patone, XW Mei, L Handunnetthi, S Dixon, F Zaccardi, M Shankar-Hari, ...
Nature medicine 28 (2), 410-422, 2022
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis
AE Handel, AJ Williamson, G Disanto, L Handunnetthi, G Giovannoni, ...
PloS one 5 (9), e12496, 2010
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
M Patone, L Handunnetthi, D Saatci, J Pan, SV Katikireddi, S Razvi, ...
Nature medicine 27 (12), 2144-2153, 2021
Regulation of major histocompatibility complex class II gene expression, genetic variation and disease
L Handunnetthi, SV Ramagopalan, GC Ebers, JC Knight
Genes & Immunity 11 (2), 99-112, 2010
A genetics-led approach defines the drug target landscape of 30 immune-related traits
H Fang, H De Wolf, B Knezevic, KL Burnham, J Osgood, A Sanniti, ...
Nature genetics 51 (7), 1082-1091, 2019
Multiple sclerosis, vitamin D, and HLA-DRB1*15
L Handunnetthi, SV Ramagopalan, GC Ebers
Neurology 74 (23), 1905-1910, 2010
Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex
M Patone, XW Mei, L Handunnetthi, S Dixon, F Zaccardi, M Shankar-Hari, ...
Circulation 146 (10), 743-754, 2022
Heterogeneity in multiple sclerosis: scratching the surface of a complex disease
G Disanto, AJ Berlanga, AE Handel, AE Para, AM Burrell, A Fries, ...
Autoimmune diseases 2011, 2010
Prodromal symptoms of multiple sclerosis in primary care
G Disanto, C Zecca, S MacLachlan, R Sacco, L Handunnetthi, UC Meier, ...
Annals of neurology 83 (6), 1162-1173, 2018
Perceptual systems controlling speech production
NS Dhanjal, L Handunnetthi, MC Patel, RJS Wise
Journal of Neuroscience 28 (40), 9969-9975, 2008
Genetic and environmental factors and the distribution of multiple sclerosis in Europe
AE Handel, L Handunnetthi, G Giovannoni, GC Ebers, SV Ramagopalan
European Journal of Neurology 17 (9), 1210-1214, 2010
Risk alleles for multiple sclerosis in multiplex families
MJ D’netto, H Ward, KM Morrison, SV Ramagopalan, DA Dyment, ...
Neurology 72 (23), 1984-1988, 2009
Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians
SM Orton, SV Ramagopalan, AE Para, MR Lincoln, L Handunnetthi, ...
Journal of the neurological sciences 305 (1-2), 116-120, 2011
MHC transmission: insights into gender bias in MS susceptibility
MJ Chao, SV Ramagopalan, BM Herrera, SM Orton, L Handunnetthi, ...
Neurology 76 (3), 242-246, 2011
The emerging role of vitamin D binding protein in multiple sclerosis
G Disanto, SV Ramagopalan, AE Para, L Handunnetthi
Journal of neurology 258, 353-358, 2011
Type 1 diabetes mellitus and multiple sclerosis: common etiological features
AE Handel, L Handunnetthi, GC Ebers, SV Ramagopalan
Nature Reviews Endocrinology 5 (12), 655-664, 2009
Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials. gov: a cross-sectional study
S Ramagopalan, AP Skingsley, L Handunnetthi, M Klingel, D Magnus, ...
F1000Research 3, 2014
The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression
AE Handel, L Handunnetthi, AJ Berlanga, CT Watson, JM Morahan, ...
PloS one 5 (4), e10142, 2010
The system can't perform the operation now. Try again later.
Articles 1–20